Abdominal Visceral and Subcutaneous Adipose Tissue Compartments: Association With Metabolic Risk Factors in the Framingham Heart Study

By Caroline S. Fox, Joseph M. Massaro, U. Hoffmann, Karla M. Pou, P. Maurovich-Horvát, Chunyu Liu, Ramachandran S. Vasan, Joanne M. Murabito, James B. Meigs, L. Cupples and 2 more. Circulation, 2007

2,830 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Epidemiology

View Paper: https://www.semanticscholar.org/paper/a8820793492ed5d7702220cb082be5f331840789

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

In Endocrinology, Diabetes and Metabolism

In Epidemiology

Citations in the corpus

The clinical importance of visceral adiposity: a critical review of methods for visceral adipose tissue analysis. (2012, background): “It has been distinctly linked to several pathological conditions including impaired glucose and lipid metabolism, insulin resistance [7, 8], increased predisposition to cancers of the colon [9], breast [10] and prostate [11], and it is associated with prolonged hospital stays, increased incidence of”
Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial (2010, background): “Of these parameters, the reduction in visceral fat stands out because an excess accumulation of visceral fat is primarily involved in metabolic disorders, and visceral fat is more strongly correlated with most metabolic risk factors than subcutaneous fat (Fox et al., 2007).”
Adiposity, Cardiometabolic Risk, and Vitamin D Status: The Framingham Heart Study (2009, positive): “glyceridemia, impaired fasting glucose, and the metabolic syndrome (16,27,50).”
Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study. (2008, neutral): “CHD (%) 6.3 (80) Myocardial infarction (%) 3.1 (39) Stroke (%) 1.5 ( 19 ) CHF (%) 0.2 (3)”
Adipose Tissue Heterogeneity: Implication of depot differences in adipose tissue for Obesity Complications (2012, background): “Central obesity, particularly visceral obesity, but also including fat accumulation in abdominal sc (apple-shaped, android), confers increased risk for metabolic complications of obesity, whereas lower or peripheral obesity, preferential fat accumulation in gluteofemoral region and leg (pear-shaped,”
Echocardiographic epicardial fat: a review of research and clinical applications. (2009, background): “Visceral fat deposition has been recognized as an important risk factor for cardiovascular disease.(42,43) The quantification of visceral fat is a helpful practical diagnostic tool for clinicians who are committed to managing patients at high risk for cardiovascular disease.”
The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. (2008, background): “Some evidence suggests that excess subcutaneous fat may have fewer adverse health effects than excess visceral fat ( 14 ).”